BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$255B |
| 2 |
Thermo Fisher Scientific
TMO
|
+$458M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$288M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 5 |
Advanced Micro Devices
AMD
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$622M |
| 2 |
Microsoft
MSFT
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 4 |
Amazon
AMZN
|
+$353M |
| 5 |
Diageo
DEO
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.42% |
| 2 | Financials | 6.29% |
| 3 | Healthcare | 5.84% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Transcat
TRNS
$877M
| $109K | ﹤0.01% |
1,445
-181
| -11% | -$12.5K |
|
3452
iRadimed
IRMD
$1.11B
| $109K | ﹤0.01% |
3,615
+1,871
| +107% | +$65.2K |
|
3453
Capital Bancorp
CBNK
$613M
| $108K | ﹤0.01% |
4,694
+345
| +8% | +$8.25K |
|
3454
Five Star Bancorp
FSBC
$1.15B
| $108K | ﹤0.01% |
+3,810
| New | +$100K |
|
3455
Red Violet
RDVT
$1.12B
| $107K | ﹤0.01% |
6,189
+4,286
| +225% | +$85.4K |
|
3456
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $107K | ﹤0.01% |
2,479
-1,101
| -31% | -$52.8K |
|
3457
CS Disco
LAW
$286M
| $107K | ﹤0.01% |
+10,652
| New | +$194K |
|
|
BGFV
3458
DELISTED
Big 5 Sporting Goods
BGFV
| $106K | ﹤0.01% |
9,893
+1,699
| +21% | +$20.5K |
|
3459
Cadre Holdings
CDRE
$1.46B
| $106K | ﹤0.01% |
+4,416
| New | +$108K |
|
3460
Matrix Service
MTRX
$335M
| $106K | ﹤0.01% |
25,613
-49,509
| -66% | -$254K |
|
|
FREE
3461
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $106K | ﹤0.01% |
+27,587
| New | +$150K |
|
3462
First Internet Bancorp
INBK
$254M
| $106K | ﹤0.01% |
3,124
+1,189
| +61% | +$43.3K |
|
|
NESR
3463
National Energy Services Reunited Corp
NESR
$3.66B
| $106K | ﹤0.01% |
17,795
-1,308
| -7% | -$8.78K |
|
3464
Aura Biosciences
AURA
$795M
| $105K | ﹤0.01% |
+5,821
| New | +$88.1K |
|
|
SAND
3465
DELISTED
Sandstorm Gold
SAND
| $105K | ﹤0.01% |
20,395
+1,500
| +8% | +$8.76K |
|
|
PSTL
3466
Postal Realty Trust
PSTL
$696M
| $105K | ﹤0.01% |
7,184
+2,834
| +65% | +$44.1K |
|
3467
AXT Inc
AXTI
$5.34B
| $105K | ﹤0.01% |
15,702
+6,661
| +74% | +$52.4K |
|
|
KALV
3468
DELISTED
KalVista Pharmaceuticals
KALV
| $105K | ﹤0.01% |
7,243
+1,285
| +22% | +$18K |
|
3469
Peoples Financial Services
PFIS
$714M
| $104K | ﹤0.01% |
2,229
+531
| +31% | +$27.4K |
|
3470
HCI Group
HCI
$2.29B
| $104K | ﹤0.01% |
2,660
+520
| +24% | +$29.8K |
|
3471
Bank First Corp
BFC
$1.75B
| $104K | ﹤0.01% |
1,363
-299
| -18% | -$23.3K |
|
3472
Civista Bancshares
CIVB
$593M
| $104K | ﹤0.01% |
5,018
-1,090
| -18% | -$23.5K |
|
|
NRT
3473
North European Oil Royalty Trust
NRT
$82M
| $104K | ﹤0.01% |
7,184
-20,560
| -74% | -$316K |
|
3474
iShares Russell 3000 ETF
IWV
$20.5B
| $104K | ﹤0.01% |
500
-4
| -0.8% | -$920 |
|
3475
Janux Therapeutics
JANX
$986M
| $103K | ﹤0.01% |
+7,638
| New | +$102K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2022 Portfolio in Review
As of Q3 2022, BNP Paribas Financial Markets held 5,152 positions worth $62.5B, down 2.4% from $64.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
BNP Paribas Financial Markets deployed $254B of net new capital in Q3 2022, opening 1,204 new positions and adding to 1,887 existing holdings. Its largest new stake was Marvell Technology: 910,010 shares worth $39M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $622M trimmed.
- BNP Paribas Financial Markets's largest Q3 2022 buy was Marvell Technology: 910,010 shares worth $39M.
- BNP Paribas Financial Markets added most to Berkshire Hathaway Class A in Q3 2022, an estimated $255B increase.
- BNP Paribas Financial Markets's biggest Q3 2022 reduction was Apple, cutting an estimated $622M.
- BNP Paribas Financial Markets fully exited Alphabet (Google) Class A in Q3 2022, selling an estimated $533M.
- BNP Paribas Financial Markets's ten largest holdings make up 12% of its $62.5B portfolio in Q3 2022.
- BNP Paribas Financial Markets opened 1,204 new positions and closed 420 in Q3 2022.
- BNP Paribas Financial Markets's portfolio value fell 2.4% quarter-over-quarter to $62.5B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.